Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Milan Longevity SummitAudio: British English

Rosa De Santis | Measuring Ageing | Milan Longevity Summit 2026

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

*Rosa De Santis, Group Leader, Institute Telethon of Genetics and Medicine-TIGEM Population genomic screening: intercepting tumors and cardiovascular diseases before symptoms* Can genomic screening identify life-threatening diseases before symptoms ever appear? In this session from Measuring Ageing: Biomarkers, Clocks, and Predictive Tools at the Milan Longevity Summit 2026, Dr. Rosa De Santis explores the transformative potential of population genomic screening to detect inherited risks for cancer and cardiovascular disease long before clinical symptoms develop. As genomic technologies become faster, more accurate, and increasingly accessible, large-scale screening programmes are opening new opportunities for preventive medicine. The discussion examines how integrating genetic information into routine healthcare could enable earlier diagnosis, personalised prevention strategies, and more effective interventions, ultimately improving healthspan and reducing the burden of chronic disease. Dr. Rosa De Santis is Group Leader at the Telethon Institute of Genetics and Medicine (TIGEM), where her research focuses on genomic medicine, hereditary disease, and the implementation of population-scale genetic screening programmes. Her work aims to translate advances in human genomics into practical tools for early disease detection and precision healthcare, with a particular focus on inherited cancer syndromes and cardiovascular diseases. The Milan Longevity Summit brings together global leaders across science, medicine, policy, business, technology and society to rethink the future of health through a One Health perspective—recognising that the wellbeing of people, planet and economies is deeply interconnected. *Learn more about the Milan Longevity Summit:* https://www.milanlongevitysummit.org/it/speakers26/rosa-de-santis #MilanLongevitySummit #Longevity #OneHealth #RosaDeSantis #Genomics #PrecisionMedicine #PreventiveMedicine #CancerPrevention #CardiovascularHealth #HealthyAgeing

Milan Longevity Summit · 17 min · Source published: 2026-08-08

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…